Catalyst Pharmaceuticals Shares Outstanding 2006-2019 | CPRX

Catalyst Pharmaceuticals shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Catalyst Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2018 103
2017 86
2016 83
2015 81
2014 64
2013 45
2012 30
2011 22
2010 19
2009 15
2008 13
2007 13
2006 8
2005 6
Catalyst Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 107
Q2 2019 106
Q1 2019 103
Q4 2018 103
Q3 2018 103
Q2 2018 103
Q1 2018 103
Q4 2017 86
Q3 2017 85
Q2 2017 84
Q1 2017 83
Q4 2016 83
Q3 2016 83
Q2 2016 83
Q1 2016 83
Q4 2015 81
Q3 2015 82
Q2 2015 82
Q1 2015 76
Q4 2014 64
Q3 2014 67
Q2 2014 66
Q1 2014 54
Q4 2013 45
Q3 2013 45
Q2 2013 41
Q1 2013 41
Q4 2012 30
Q3 2012 32
Q2 2012 27
Q1 2012 25
Q4 2011 22
Q3 2011 22
Q2 2011 22
Q1 2011 20
Q4 2010 19
Q3 2010 19
Q2 2010 18
Q1 2010 18
Q4 2009 15
Q3 2009 14
Q2 2009 14
Q1 2009 14
Q4 2008 13
Q3 2008 13
Q2 2008 13
Q1 2008 13
Q4 2007 13
Q3 2007 13
Q2 2007 13
Q1 2007 13
Q4 2006 8
Q3 2006 7
Q2 2006 7
Q1 2006 7
Q3 2005 7
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.537B $0.001B
Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), anti-MuSK antibody positive myasthenia gravis (MuSK-MG), congenital myasthenic syndromes (CMS), and spinal muscular atrophy (SMA) Type 3.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $67.550B 39.07
Takeda Pharmaceutical (TAK) Japan $58.571B 10.38
Astellas Pharma (ALPMY) Japan $32.091B 16.03
Eisai (ESALY) Japan $22.967B 44.28
UCB SA (UCBJF) Belgium $18.867B 0.00
Grifols, S.A (GRFS) Spain $17.622B 23.09
Merck (MKGAF) Germany $17.318B 23.63
Neurocrine Biosciences (NBIX) United States $9.609B 266.97
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Catalent (CTLT) United States $8.636B 35.53
Ionis Pharmaceuticals (IONS) United States $8.509B 17.23
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.627B 9.74
IPSEN SA ADR (IPSEY) France $6.090B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.877B 0.00
Orion OYJ (ORINY) Finland $5.871B 0.00
STADA ARZNEIMI (STDAF) Germany $5.543B 0.00
Hypermarcas (HYPMY) Brazil $5.178B 15.75
United Therapeutics (UTHR) United States $4.694B 0.00
Nektar Therapeutics (NKTR) United States $4.139B 0.00
Evotec AG (EVTCY) Germany $4.138B 66.78
FibroGen (FGEN) United States $3.968B 116.61
Arrowhead Pharmaceuticals (ARWR) United States $3.913B 72.62
Sage Therapeutics (SAGE) United States $3.603B 0.00
PTC Therapeutics (PTCT) United States $3.524B 0.00
ChemoCentryx (CCXI) United States $2.837B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.802B 11.34
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.277B 0.00
Pacira Pharmaceuticals (PCRX) United States $2.024B 55.74
Xencor (XNCR) United States $1.995B 60.64
Tilray (TLRY) Canada $1.947B 0.00
Heron Therapeutics (HRTX) United States $1.932B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.840B 22.36
Corcept Therapeutics (CORT) United States $1.553B 17.42
USANA Health Sciences (USNA) United States $1.525B 15.94
Theravance Biopharma (TBPH) Cayman Islands $1.463B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.392B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.391B 9.49
Endo (ENDP) Ireland $1.377B 2.53
Zogenix (ZGNX) United States $1.335B 0.00
Akebia Therapeutics (AKBA) United States $1.207B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.060B 32.84
Portola Pharmaceuticals (PTLA) United States $1.051B 0.00
Karyopharm Therapeutics (KPTI) United States $1.010B 0.00
Aerie Pharmaceuticals (AERI) United States $1.000B 0.00
Radius Health (RDUS) United States $0.894B 0.00
ImmunoGen (IMGN) United States $0.810B 0.00
Collegium Pharmaceutical (COLL) United States $0.802B 0.00
Flexion Therapeutics (FLXN) United States $0.661B 0.00
Molecular Templates (MTEM) United States $0.659B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.571B 0.00
TherapeuticsMD (TXMD) United States $0.559B 0.00
Ardelyx (ARDX) United States $0.528B 0.00
Translate Bio (TBIO) United States $0.474B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.470B 20.27
Organogenesis Holdings (ORGO) United States $0.458B 0.00
Innate Pharma SA (IPHYF) France $0.446B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.419B 0.00
DURECT (DRRX) United States $0.417B 0.00
Calithera Biosciences (CALA) United States $0.402B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.386B 0.00
Recro Pharma (REPH) United States $0.384B 0.00
Siga Technologies (SIGA) United States $0.383B 8.76
BioCryst Pharmaceuticals (BCRX) United States $0.378B 0.00
Harpoon Therapeutics (HARP) United States $0.377B 0.00
Lannett Co Inc (LCI) United States $0.369B 5.94
Indivior (INVVY) United States $0.356B 2.11
Corbus Pharmaceuticals Holdings (CRBP) United States $0.355B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.352B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.343B 0.00
Rafael Holdings (RFL) United States $0.333B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.330B 0.00
Concert Pharmaceuticals (CNCE) United States $0.327B 0.00
OptiNose (OPTN) United States $0.310B 0.00
Ocular Therapeutix (OCUL) United States $0.272B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.269B 0.00
MEI Pharma (MEIP) United States $0.251B 0.00
KalVista Pharmaceuticals (KALV) United States $0.249B 0.00
IMV INC (IMV) Canada $0.238B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.221B 0.00
Nature's Sunshine Products (NATR) United States $0.199B 34.30
Taiwan Liposome (TLC) Taiwan $0.195B 0.00
Jounce Therapeutics (JNCE) United States $0.175B 2.35
Galmed Pharmaceuticals (GLMD) Israel $0.130B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.125B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.123B 0.00
Xeris Pharmaceuticals (XERS) United States $0.118B 0.00
CannTrust Holdings (CTST) Canada $0.117B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.114B 0.00
Otonomy (OTIC) United States $0.109B 0.00
Redhill Biopharma (RDHL) Israel $0.107B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.106B 0.00
Aquestive Therapeutics (AQST) United States $0.106B 0.00
CV Sciences (CVSI) United States $0.087B 0.00
Infinity Pharmaceuticals (INFI) United States $0.083B 0.00
Neos Therapeutics (NEOS) United States $0.082B 0.00
Champions Oncology (CSBR) United States $0.081B 0.00
MediWound (MDWD) Israel $0.081B 0.00
Onconova Therapeutics (ONTX) United States $0.074B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.068B 20.45
Entasis Therapeutics Holdings (ETTX) United States $0.068B 0.00
CTI BioPharma (CTIC) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.064B 0.00
Nivalis Therapeutics (ALPN) United States $0.060B 0.00
Aclaris Therapeutics (ACRS) United States $0.060B 0.00
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.053B 0.00
VAXART, INC (VXRT) United States $0.052B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.052B 0.00
Natural Alternatives (NAII) United States $0.051B 23.03
Forward Pharma (FWP) Denmark $0.049B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.046B 0.00
PolarityTE (PTE) United States $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.042B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
Jaguar Animal Health (JAGX) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.031B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.029B 0.00
Vical (BBI) United States $0.027B 0.00
Biomerica (BMRA) United States $0.027B 0.00
PharmAthene (ALT) United States $0.027B 0.00
China SXT Pharmaceuticals (SXTC) China $0.026B 0.00
ProPhase Labs (PRPH) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Cardiome Pharma (CORV) Canada $0.016B 0.00
Shineco (TYHT) China $0.016B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
Novan (NOVN) United States $0.015B 0.00
HANCOCK JAFFE (HJLI) United States $0.013B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
Lipocine (LPCN) United States $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00